CSL (ASX: CSL) – CSL signs exclusive Alentis Therapeutics deal
CSL Limited has entered an exclusive agreement with Alentis Therapeutics to co-develop and co-promote lixudebart, a potential first-in-class...
CSL Limited has entered an exclusive agreement with Alentis Therapeutics to co-develop and co-promote lixudebart, a potential first-in-class...
The scheme booklet for oOh!media Limited's proposed acquisition by I Squared Capital-backed OOH BidCo Pty Ltd has now been despatched to...
Steadfast Group Limited (ASX: SDF) has disclosed receipt of a notice from Pentwater Capital Management LP regarding equity derivatives holdings...
Lendlease has extended the completion deadline for its sale of Milano Santa Giulia (MSG North) development rights in Italy to 15 October 2026,...
Data#3 has guided to notably strong first half FY27 earnings growth, with consolidated net profit before tax expected to exceed 40% above the prior...